Inhibrx, Inc. Ex-distribution When-Issued (INBXV) Stock Analysis
DELISTED
What happened to Inhibrx, Inc. Ex-distribution When-Issued (INBXV) stock?
Inhibrx, Inc. Ex-distribution When-Issued (INBXV) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $1.57B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Inhibrx, Inc. Ex-distribution When-Issued (INBXV). Inhibrx, Inc. Ex-distribution When-Issued (INBXV) is a biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. The company leverages its proprietary protein engineering platform to create differentiated therapies for unmet medical needs.
Last analyzed: Mar 17, 2026Inhibrx, Inc. Ex-distribution When-Issued (INBXV) Healthcare & Pipeline Overview
More about this archive record
Can I still buy INBXV shares?
No. INBXV stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for INBXV elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before INBXV stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Inhibrx, Inc. Ex-distribution When-Issued. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.